Integrated Solutions for Cell and Gene Therapy

Therapeutic, serum-free cell-culture media enabling robust, consistent and cost-efficient processes for cell and gene therapies.

The LV Unit expands our proven 4D-Nucleofector^® System to closed, scalable transfection of larger cell numbers in the range of 1x10⁷ to 1x10⁹ cells in research or GMP environments. 

A configurable and flexible electronic batch record solution for paperless data capture in laboratories and manufacturing facilities with GMP compliance and tracking at its core.

The Bacterial Endotoxin Test (BET) is a crucial safety requirement for end-product release. Our regulatory compliant BET products and services ensure your cell therapies can be used with confidence.

Watch our team demonstrate the 4D-Nucleofector^® LV Unit for efficient large-scale electroporation and learn about the technology’s benefits for ex vivo genetic modification in cell and gene therapy manufacturing. 

Learn how Lonza’s Cocoon^® Platform, 4D-Nucleofector^® LV Unit and X-VIVO^® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.

Case study examining how MES Solutions improve operational efficiency and save costs.  MES solutions can remove paper from the manufacturing floor— while boosting operational efficiency and saving costs.

Cell and gene therapy are a hot topic, but are you aware of the requirements around endotoxin testing for these products? Here is a short overview.